The liver is the central metabolic organ and plays a pivotal role in regulating homeostasis of
glucose and lipid metabolism. Aberrant liver metabolism promotes insulin resistance, which …

Nonalcoholic fatty liver disease (NAFLD), hepatic insulin resistance, and type 2 diabetes are
all strongly associated and are all reaching epidemic proportions. Whether there is a causal …

Obesity is less common in the Asian population, but Asian people may be susceptible to
obesity-associated metabolic dysregulation. Accumulating evidence suggests that insulin …

Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for advanced liver
disease, type 2 diabetes (T2DM), and cardiovascular diseases. The prevalence of NAFLD in …

Insulin resistance (IR) is defined as a lower-than-expected response to insulin action from
target tissues, leading to the development of type 2 diabetes through the impairment of both …

Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver
diseases worldwide, causing considerable liver-related mortality and morbidity. Over the last …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder globally
impacting an estimated 25% of the population associated with severe consequences such …

Non-alcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease in
the developed countries. There is also growing evidence from basic and clinical research …

Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) remain as one
of the most global problematic metabolic diseases with rapidly increasing prevalence and …

Nonalcoholic fatty liver disease (NAFLD) has an estimated prevalence of 25% in the general
population, and cirrhosis secondary to nonalcoholic steatohepatitis (NASH) is predicted to …